Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (381-390 of 598) with videos related to

Pageof 60
Sort By:
Molecular Cancer|September 26, 2024
A high proportion of germline variants in pediatric chronic myeloid leukemiaManuela Krumbholz, Anna Dolnik, Eric Sträng, et al.
Blood|May 12, 2009
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic featuresClaudia Haferlach, Cristina Mecucci, Susanne Schnittger, et al.
Blood|April 21, 2017
Response and progression on midostaurin in advanced systemic mastocytosis: <i>KIT</i> D816V and other molecular markersMohamad Jawhar, Juliana Schwaab, Nicole Naumann, et al.
International Journal of Molecular Sciences|February 15, 2019
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AMLPeter Valent, Wolfgang Kern, Gregor Hoermann, et al.
Blood Advances|October 24, 2023
The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencingAnna Maierhofer, Nikita Mehta, Ryan A Chisholm, et al.
Iscience|January 10, 2020
Scalable Prediction of Acute Myeloid Leukemia Using High-Dimensional Machine Learning and Blood TranscriptomicsStefanie Warnat-Herresthal, Konstantinos Perrakis, Bernd Taschler, et al.
Blood|June 28, 2011
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3Christoph Walz, Philipp Erben, Michael Ritter, et al.
Genes, Chromosomes & Cancer|July 18, 2006
Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion geneChristoph Walz, Claire Curtis, Susanne Schnittger, et al.
Seminars in Cancer Biology|June 13, 2021
Analytical demands to use whole-genome sequencing in precision oncologyManja Meggendorfer, Vaidehi Jobanputra, Kazimierz O Wrzeszczynski, et al.
Blood|May 10, 2011
PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemiaMaria Kleppe, Jean Soulier, Vahid Asnafi, et al.
Pageof 60

Showing results (381-390 of 598) with videos related to

Sort By:
Pageof 60
Molecular Cancer|September 26, 2024
A high proportion of germline variants in pediatric chronic myeloid leukemiaManuela Krumbholz, Anna Dolnik, Eric Sträng, et al.
Blood|May 12, 2009
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic featuresClaudia Haferlach, Cristina Mecucci, Susanne Schnittger, et al.
Blood|April 21, 2017
Response and progression on midostaurin in advanced systemic mastocytosis: <i>KIT</i> D816V and other molecular markersMohamad Jawhar, Juliana Schwaab, Nicole Naumann, et al.
International Journal of Molecular Sciences|February 15, 2019
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AMLPeter Valent, Wolfgang Kern, Gregor Hoermann, et al.
Blood Advances|October 24, 2023
The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencingAnna Maierhofer, Nikita Mehta, Ryan A Chisholm, et al.
Iscience|January 10, 2020
Scalable Prediction of Acute Myeloid Leukemia Using High-Dimensional Machine Learning and Blood TranscriptomicsStefanie Warnat-Herresthal, Konstantinos Perrakis, Bernd Taschler, et al.
Blood|June 28, 2011
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3Christoph Walz, Philipp Erben, Michael Ritter, et al.
Genes, Chromosomes & Cancer|July 18, 2006
Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion geneChristoph Walz, Claire Curtis, Susanne Schnittger, et al.
Seminars in Cancer Biology|June 13, 2021
Analytical demands to use whole-genome sequencing in precision oncologyManja Meggendorfer, Vaidehi Jobanputra, Kazimierz O Wrzeszczynski, et al.
Blood|May 10, 2011
PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemiaMaria Kleppe, Jean Soulier, Vahid Asnafi, et al.
Pageof 60